Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes

Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes

Magnetic drug targeting (MDT) improves the integrity of healthy tissues and cells during treatment with cytotoxic drugs. An anticancer drug is bound to superparamagnetic iron oxide nanoparticles (SPION), injected into the vascular supply of the tumor and directed into the tumor by means of an extern...

Full description

Bibliographic Details
Main Authors: Christina Janko, Stephan Dürr, Luis E. Munoz, Stefan Lyer, Ricardo Chaurio, Rainer Tietze, Sarah von Löhneysen, Christine Schorn, Martin Herrmann, Christoph Alexiou
Format: Article
Language:English
Published: MDPI AG 2013-04-01
Series:International Journal of Molecular Sciences
Subjects:
chemotherapy
iron oxide nanoparticles
mitoxantrone
magnetic drug targeting
immune system
leukocytes
Online Access:http://www.mdpi.com/1422-0067/14/4/7341

Internet

http://www.mdpi.com/1422-0067/14/4/7341

Similar Items